Pharmacogenomics is transforming clinical practice by enabling therapy decisions tailored to an individual’s genetic profile. This session focuses on how genetic variability influences drug response, efficacy, and toxicity, helping clinicians move toward more precise and personalized treatment strategies across oncology and other therapeutic areas.
Beyond current clinical applications, the session will also explore the future of precision medicine through the integration of pharmacogenomics with emerging multi-omics platforms, including transcriptomics, proteomics, and spatial genomics, and their role in advancing personalized therapeutic decision-making.
